Update, November 4, 2026
Since the October 28 report, Starbucks (SBUX) has risen to $106.84, up 1.98% on the day and 3.53% over the past five trading sessions, out‑performing the S&P 500’s –1.99% decline and beating the consumer‑discretionary XLY’s 1.63% gain. The rally is driven by a strong earnings beat that showed non‑GAAP EPS of $0.80 (+54% YoY) and U.S. comparable sales up 7.7%, reinforcing the stock’s momentum.
The picture holds – the daily trend remains aligned with the longer‑term uptrend, and none of the key rules have been triggered. The swing‑zone support at $102.21 and the SMA‑200 at $100.03 remain intact, while the 52‑week high target of $108.55 is still the next breakout level. A weekly close below the SMA‑50 at $99.17 would be required to change the picture.
Recent news supports the bullish bias: Investing.com highlighted the earnings beat and margin expansion, and Bloomberg Business noted the product line adjustment, which management says reflects a focus on higher‑margin items. Both events underscore the firm’s operational momentum as it heads toward its January 27 earnings.
Starbucks Corporation (SBUX) trades at $103.36, a fresh recent peak, one day before it reports earnings on October 29, 2026. The stock has gained 4.3% in five days while the S&P 500 and the consumer discretionary sector both slipped, and the daily and weekly trends now point the same way. The balance of evidence leans positive with high conviction, a step up from last week's neutral. The test is $108.55.
Why it matters
The event is tomorrow's earnings, and this week's move has no obvious news behind it. The company raised its quarterly dividend by a cent to $0.63, the 16th straight annual increase, The Motley Fool reports, payable November 27 to holders of record on November 13. A Bloomberg briefing mentioned a seating policy change in China. International CEO Brady Brewer sold 588 shares at $100.00, a $58,800 sale made under a trading plan Investing.com says was adopted on December 3, 2025. None of this explains a 4.3% jump. The news does not account for the move, so it is better treated as buyers positioning ahead of the report.
Almost none of the move came from outside the stock. Over five days SBUX rose 4.3% while SPY fell 0.4% and XLY fell 0.4%, so the stock beat its sector by 4.7 points. Over a month it is up 8.5%, against 0.6% for SPY and 5.6% for XLY. Year to date it is up 22.7%, against 13.0% for SPY and a 3.6% loss for XLY. With the RSI at 77.5, a good deal of optimism is already in the price before the numbers arrive.
The argument about the company is a real one. The cautious side is Seeking Alpha, where an author who turned negative in September 2025 notes the shares have risen about 18% since. The author says the margin damage from a roughly 300% rise in coffee prices was real, but the market did not respond as expected. The Motley Fool adds that growth has slowed markedly from its pre-pandemic pace, leaving a 2.6% yield as the main attraction. The constructive side rests on the dividend record and on pricing power: TheStreet found a medium iced vanilla latte at $6.05 in Starbucks, against $5.20 at 7 Brew. Customers are paying a premium, though that gap is also a vulnerability. Coca-Cola's difficulty turning a $5 billion Costa Coffee purchase into a global platform, Bloomberg reports, shows how hard the coffee business is to scale.
Valuation leaves modest room. Twenty-nine analysts rate the stock a buy, with a mean price target of $109.93, 6.0% above the current price. Targets run from $82 to $136, and the mean sits just above the 52-week high of $108.55. At a market value of about $117.8 billion, the stock is priced near the middle of what analysts expect, not at a discount.
What the evidence says
The long-term thesis is intact. Price is above its 40-week average and 29.85% above the 52-week low of $79.60, and it sits 4.78% below the 52-week high. The 50-day average at $99.26 and the 200-day at $99.71 sit close together just under the price, so the stock has repaired its averages and is now advancing toward its prior high.
For the next 2 to 6 weeks the balance of evidence leans positive, with high conviction (3 of 4 points). This changes the earlier reading. The report of October 20, 2026 was neutral with low conviction: the daily trend did not line up with the weekly uptrend, and the line that would have changed the picture was a weekly close below $96.59. Since then the daily trend has come into line with the weekly uptrend, and the stock leads the S&P 500 by 3.7% and XLY by 2.6% over 50 days. Trend alignment and relative strength carry the upgrade. The line that would change the picture has moved up with the price, to $99.26.
The strongest case against is the stretch and the calendar. The RSI is 77.5, the stock is up 8.5% in a month, earnings land tomorrow, the price is 6.0% under the mean target, and the stock still trails SPY by 2.2% over 200 days. Early volume today is a small fraction of the 20-day average, though that says little this early in the session. Those facts describe a stock that has run, and they keep the reading from being unconditional. They do not tip the balance because they measure stretch, not direction. The trend, the leadership over both the market and the sector, and the nearby support all still favor the buyers.
Levels that matter
The structure stays intact above $102.21, a swing zone just under the current price. A move below it would be the first crack. Underneath sits a cluster: the round $100, the 200-day average at $99.71 and the 50-day at $99.26. The trend ends below $99.26 because that is the 50-day average, and losing it, on a weekly close, would mean the advance has given back the support that carried it. Below that, $96.59 and $93.20 are the next swing zones.
The breakout level is a daily close above $108.55, the 52-week high, on volume above its 20-day average. From there the first target is $125 and the second $150, both round numbers. The breakout is wrong below $101.67, which is the $102.21 swing zone less a quarter of the 14-day ATR of $2.16. Against that stop the math gives 2.4 to 1 to $125 and 6 to 1 to $150. It clears the 3 to 1 mark only toward the far target.
What would change the picture
A weekly close below $99.26, the 50-day average, would change the picture. The non-price fact that would most likely do it is tomorrow's earnings report showing coffee costs and weaker traffic cutting into margins harder than shares have priced in. That would be the evidence behind the slower-growth, margin-pressure argument that the negative commentary leans on.
What to watch
- Earnings, October 29, 2026: the number that matters is U.S. comparable-store sales, because it shows whether demand supports the premium price.
- Sector and macro: CNBC flags a Federal Reserve meeting, fresh inflation data and midterm elections less than 10 days away. Each can move consumer discretionary names, including XLY, before SBUX's own news.
- Valuation: at $103.36 the stock is 6.0% below the $109.93 mean target, and the mean is close to the $108.55 high it has yet to clear.